Natriuretic peptides as predictors for atrial fibrillation recurrence after catheter ablation: A meta-analysis

Yujing Yuan1, Boyuan Nie2, Binbin Gao1

  • 1Department of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, People's Republic of China.

Medicine
|May 12, 2023
PubMed

Insights

Higher baseline natriuretic peptide levels, including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), predict atrial fibrillation (AF) recurrence after catheter ablation (CA). These findings highlight natriuretic peptides as potential biomarkers for AF management post-CA.

Area of Science:

  • Cardiology
  • Biomarkers
  • Electrophysiology

Background:

  • Catheter ablation (CA) is a primary treatment for atrial fibrillation (AF), but recurrence remains a significant clinical challenge.
  • Identifying predictors of AF recurrence post-CA is crucial for optimizing patient outcomes and treatment strategies.

Approach:

  • A comprehensive meta-analysis was conducted, systematically searching major scientific databases (PubMed, EMBASE, Web of Science, Wiley-Cochrane Library) up to May 2022.
  • Sixty-one studies were included, analyzing baseline natriuretic peptide levels in relation to AF recurrence after CA using overall and subgroup effect analyses.

Key Points:

  • Elevated baseline levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), N-terminal pro-BNP, and midregional N-terminal pro-ANP were significantly associated with increased AF recurrence.
  • Specific standardized mean differences (SMDs) and 95% confidence intervals (CIs) were reported for each peptide, indicating the strength of association.

Conclusions:

  • Increased baseline natriuretic peptide concentrations are linked to a higher risk of AF recurrence following catheter ablation.
  • Further research is warranted to fully elucidate the predictive utility of these natriuretic peptides in AF patients undergoing CA.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
473
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
18
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
55
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
433
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
80